The Centers for Medicare and Medicare Services has declined to expand the Medicare Part B colorectal cancer screening benefit to include coverage of PreGen-Plus™ , a commercially available screening DNA stool test, as an alternative to a screening colonoscopy or a screening flexible sigmoidoscopy.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

August 13, 2008 - Table of Contents

NIR August 13, 2008 (full PDF issue)

Push Is on to Overhaul Medicare Physician, Lab Payments

Delay Seen in Switch to New Single ABN

CMS Seeks Dismissal of Lab Bidding Demo Lawsuit

OIG Assures Providers on Waivers of Beneficiary Cost Sharing

Medicare Nixes Stamped Physician Signatures

New Bill Aims to Modernize Medicare Lab Fee Schedule

Prothrombin Time Home Monitoring

DNA Stool Screening Test for Colorectal Cancer

CMS Finalizes Stark ‘Stand in the Shoes’ Provisions